Solasia Pharma KK (4597) Stock Price & News

Why is 4597 down 4.17%?

Dive Deeper

4597:TYO

Solasia Pharma KK

¥23.00

-4.17%

(-1.00) 1D

Nov 6, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4597...

Open

¥23

High

¥24

Low

¥22

Mkt. cap

6.29B

Avg. vol.

80.15M

Volume

88.60M

52-wk high

¥42

52-wk low

¥21

EPS

-¥3

Shares outstanding

104.68M

No. of employees

Open

¥23

High

¥24

Low

¥22

Mkt. cap

6.29B

Avg. vol.

80.15M

Volume

88.60M

52-wk high

¥42

52-wk low

¥21

EPS

-¥3

Shares outstanding

104.68M

No. of employees

Related stocks

4564

OncoTherapy Science, Inc.

News stories

From web sources and news partners

marketscreener.com

43 minutes ago

Out of the blue

Yahoo Finance

1 hour ago

Invesco S&P 500 Equal Weight (RSP) Adds Okta and Moderna on Nov. 4

MarketForces Africa

2 hours ago

Global Markets Tumble On Tech Stocks Rout, Nasdaq, S&P 500 Fall

Moomoo

11 minutes ago

Dow Jones Top Financial Services Headlines at 7 AM ET: Monte Dei Paschi Raises Profit Guidance as Intesa Prepares to Launch Takeover Bid | Hong ...

About Solasia Pharma KK

CEOYoshihiro Arai

Employees22

Founded2006

Headquarters-

SectorHealth Care

IndustryBiotechnology

Websitesolasia.co.jp

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	42.00M	338.00M	6.00M	2.00M
Cost of goods sold	1.00M	191.00M	1.00M	-
Cost of revenue	1.00M	191.00M	1.00M	-
Research and development expenses	82.00M	116.00M	112.00M	118.00M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	134.00M	178.00M	198.00M	149.00M
Operating expense	216.00M	294.00M	310.00M	267.00M
Total operating expenses	217.00M	485.00M	311.00M	267.00M
Operating income	-175.00M	-147.00M	-305.00M	-265.00M
Other non operating income	-3.00M	-1.00M	1.00M	-1.00M
EBT including unusual items	-171.00M	-150.00M	-307.00M	-272.00M
EBT excluding unusual items	-171.00M	-150.00M	-307.00M	-272.00M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-171.00M	-150.00M	-307.00M	-272.00M
Net profit margin	-407.14%	-44.38%	-5,116.67%	-13,600.00%
Earnings per share	-	-	-	-
Interest and investment income	7.00M	-	1.00M	-
Interest expense	-	-1.00M	-4.00M	-6.00M
Net interest expenses	7.00M	-1.00M	-3.00M	-6.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	-165.00M	-138.00M	-296.00M	-256.00M
Gain or loss from assets sale	-	-	-	-

Ask anything